| RHHBF Stock | | | USD 288.23 2.52 0.88% |
CFO
Dr. Alan Hippe was Member of the Corporationrationrate Executive Committee, Chief Financial Officer and Information Technology Officer at Roche Holding Ltd since April 1, 2011. Between 1993 and 1996 Dr. Hippe was Research Assistant and Teaching Assistant at the Universities of Mainz and Mannheim. In 1996 he joined AVECO Holding AG as Head of group controlling and IT systems. He served as Member of the Executive Board of Continental AG from 2002 to 2009. In April 2009 he was appointed Chief Financial Officer and Member of Executive Board of ThyssenKrupp AG. since 2011.
| Age | 56 |
| Tenure | 13 years |
| Phone | 41 61 688 11 11 |
| Web | https://www.roche.com |
Roche Holding Management Efficiency
The company has return on total asset
(ROA) of
0.1468 % which means that it generated a profit of $0.1468 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity
(ROE) of
0.4483 %, meaning that it generated $0.4483 on every $100 dollars invested by stockholders. Roche Holding's management efficiency ratios could be used to measure how well Roche Holding manages its routine affairs as well as how well it operates its assets and liabilities.
Roche Holding AG has accumulated 16.08
B in total debt with debt to equity ratio
(D/E) of 1.0, which is about average as compared to similar companies. Roche Holding AG has a current ratio of 1.09, suggesting that it
may have difficulties to pay its financial obligations in time and when they become due. Debt can assist Roche Holding until it has trouble settling it off, either with new capital or with free cash flow. So, Roche Holding's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Roche Holding AG sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Roche to invest in growth at high rates of return. When we think about Roche Holding's use of debt, we should always consider it together with cash and equity.
Similar Executives
Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Switzerland, Germany, the United States, Austria, Netherlands, the United Kingdom, France, Belgium, and internationally. The company was founded in 1896 and is headquartered in Basel, Switzerland. ROCHE HOLDINGS operates under Drug ManufacturersGeneral classification in the United States and is traded on OTC Exchange. It employs 100920 people. Roche Holding AG [RHHBF] is traded as part of a regulated electronic over-the-counter service offered by the NASD.
Management Performance
Roche Holding AG Leadership Team
Elected by the shareholders, the Roche Holding's board of directors comprises two types of representatives: Roche Holding inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Roche. The board's role is to monitor Roche Holding's management team and ensure that shareholders' interests are well served. Roche Holding's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Roche Holding's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Barbara Schadler, Head Communications | |
| Claudia Bockstiegel, G Counsel | |
| Bruno Eschli, Head Relations | |
| Johannes MD, Head Devel | |
| Thomas Schinecker, Chief Diagnostics | |
| Cristina Wilbur, Member of the Executive Committee, Head Group Human Resources | |
| William Anderson, Member of the Corporate Executive Committee, CEO Roche Pharmaceuticals | |
| Alan Hippe, CFO and IT Officer | |
| Severin Schwan, CEO and Director | |
| Pascale Schmidt, Chief Officer | |
Roche Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right otc stock is not an easy task. Is Roche Holding a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Currently Active Assets on Macroaxis
Other Information on Investing in Roche OTC Stock
Roche Holding financial ratios help investors to determine whether Roche OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Roche with respect to the benefits of owning Roche Holding security.